• Department of General Surgery, Ruijin Hospital Affiliated to Shanghai Jiaotong University, Shanghai Institute of Digestive Surgery, Shanghai 200025, China;
DENGXia-xing, Email: kejiadxx@hotmail.com
Export PDF Favorites Scan Get Citation

Objective To discuss the feasibility, safety, and superiority of da Vinci surgery system (DVSS) in liver tumor resection. Method The clinical data of 21 patients who underwent DVSS in the liver tumor resection were analyzed retrospectively. Results There were 12 patients with hepatocellular carcinoma (HCC), 1 patient with cholang-iocellular carcinoma, 1 patient with hepatic cirrhosis regenerative nodule, 2 patients with metastatic adenocarcinoma, 2 patients with leiomyosarcoma, and 3 patients with cavernous hemangioma.The operative time was (156.67±92.19) min (60-480 min), the intraoperative blood loss was (585.71±1 076.12) mL (50-5 000 mL), the time of diet recovery was (3.23±1.26) d (2-6 d), and the hospital stay was (10.10±9.02) d (5-47 d).The hospital mortality and morbidity rates were 0(0/21) and 9.52%(2/21) respectively including 1 patient with biliary leakage and 1 patient with abdominal infection. Conclusion This study demonstrates the feasibility and safety of DVSS in the liver tumor resection and the system has a wide range of application for patients who are suffering from liver tumor.

Citation: LIUXue-qian, ZHANGTian, DENGXia-xing, PENGCheng-hong, SHENBai-yong, WANGXin-jing, GULei, WENChen-lei. Clinical Summary of da Vinci Surgery System in Liver Tumor Resection. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2014, 21(2): 146-149. doi: 10.7507/1007-9424.20140034 Copy

  • Previous Article

    华西围术期输血指征评分——以临床需求为目标的输血评分
  • Next Article

    Effects of Leukocyte Filtration on Blood Components and Cytokines of Residual Pump Blood after Cardiopulmonary Bypass: A Randomized Controlled Trial